IL22 and chronic obstructive pulmonary disease: The number of IL-17A+ and IL-22+ immunoreactive cells is increased in the bronchial submucosa of stable COPD compared with control nonsmokers [39] although the expression of IL-17F and IL-21 is not significant different among subject groups [39].